{"entity":{"id":"cambridge-cancer-genomics","kind":"company","name":"Cambridge Cancer Genomics (CCG.ai)","aka":[],"tldr":"CCG.ai built software to combine genomic and clinical data so oncologists could choose and adjust treatment sooner. The company is no longer active.","summary":"Cambridge Cancer Genomics developed a data-driven precision oncology platform: software to analyse tumour and liquid biopsy sequencing alongside clinical records, and machine-learned biomarkers intended to predict treatment response and detect relapse earlier than imaging. It grew to a team of about 25 in Cambridge before the YC directory marked it inactive. It is recorded as wound down; no acquirer is named because none was found in a primary source.","asOf":"2026-09-10","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/cambridge-cancer-genomics"},{"label":"Official website","url":"https://ccg.ai"}],"tags":["yc"],"related":[],"cancers":[],"sections":["ai-computation","diagnostics"],"technologies":["liquid-biopsy","cgp"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Cambridge","country":"GB","companyType":"ai-software","website":"https://ccg.ai","stage":"defunct","ycBatch":"S17","investors":["y-combinator"],"funding":[]},"route":"/companies/cambridge-cancer-genomics/","neighbours":{"section":[{"id":"ai-computation","kind":"section","name":"AI & Computation","route":"/fronts/ai-computation/"},{"id":"diagnostics","kind":"section","name":"Diagnostics & Biomarkers","route":"/fronts/diagnostics/"}],"technology":[{"id":"cgp","kind":"technology","name":"Comprehensive genomic profiling","route":"/technologies/cgp/"},{"id":"liquid-biopsy","kind":"technology","name":"Liquid biopsy (ctDNA)","route":"/technologies/liquid-biopsy/"}],"company":[{"id":"y-combinator","kind":"company","name":"Y Combinator","route":"/companies/y-combinator/"}]}}